He has completed more than 450 mergers and acquisitions and financing transactions.

Les is a frequent author, speaker, and commentator on health care and business matters as well as a contributor to Robinson+Cole’s health law blog, Health Law Diagnosis. Prior to joining our firm, he was a partner at Edwards Wildman, where he was the chair of the health care practice. Les serves on a number of outside advisory boards, including the National Advisory Board of Bioethics International.

Mergers + Acquisitions

In his transactional practice, Les represents health care, life science, corporate and private equity clients, and other public and privately owned companies in a wide range of domestic and cross-border merger and acquisition transactions, including leveraged buyouts. He advises buyers and sellers on structuring transactions and negotiating acquisition and financing agreements.

Venture Capital + Equity Financings

Les counsels emerging, high-growth companies and entrepreneurs in capital raise transactions, including advice in connection with investment purchase agreements, convertible notes, charter documents, stockholder agreements, and operating agreements.

General Corporate Matters

Les also maintains an active corporate and business law practice, with an emphasis on transactional matters, including M+A for both public and private companies, securities matters, credit and finance transactions, restructurings and workouts, commercial and business agreements of all kinds, and business counseling. He regularly counsels boards and board committees, and he has served as corporate secretary to public and private companies.

Regulatory

Les provides counsel to health care providers on federal and state licensure change of control, Medicare and Medicaid fraud and abuse, compliance with the Stark law, false claims, licensure, government investigations and reimbursement matters.